Reiter RJ, Ma Q, Sharma R. Melatonin in Mitochondria: Mitigating Clear and Present Dangers. Physiol (Bethesda Md). 2020;35:86–95.

CAS  Google Scholar 

Hardeland R. COVID-19: Urgent Need to Redesign Anti-inflammatory Strategies for CNS Protection. Central nervous system agents in medicinal chemistry. 2022.

Favero G, Moretti E, Bonomini F, Reiter RJ, Rodella LF, Rezzani R. Promising antineoplastic actions of melatonin. Front Pharmacol. 2018;9:1086.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Monayo SM, Liu X. The prospective application of melatonin in treating epigenetic dysfunctional diseases. Frontiers in Pharmacology. 2022:1593.

Korkmaz A, Reiter RJ. Epigenetic regulation: a new research area for melatonin? J Pineal Res. 2008;44:41–4.

CAS  PubMed  Google Scholar 

Lerner AB, Case JD, Takahashi Y, Lee TH, Mori W. Isolation of melatonin, the pineal gland factor that lightens melanocyteS1. J Am Chem Soc. 1958;80:2587-.

CAS  Article  Google Scholar 

Tan D-X, Zheng X, Kong J, Manchester LC, Hardeland R, Kim SJ, et al. Fundamental issues related to the origin of melatonin and melatonin isomers during evolution: relation to their biological functions. Int J Mol Sci. 2014;15:15858–90.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Paredes SD, Korkmaz A, Manchester LC, Tan D-X, Reiter RJ. Phytomelatonin: a review. J Exp Bot. 2009;60:57–69.

CAS  PubMed  Article  Google Scholar 

Reiter RJ, Tan D-x, Manchester LC, Simopoulos AP, Maldonado MD, Flores LJ, et al. Melatonin in edible plants (phytomelatonin): identification, concentrations, bioavailability and proposed functions. World Rev Nutr Diet. 2007;97:211–30.

CAS  PubMed  Google Scholar 

Manchester LC, Coto-Montes A, Boga JA, Andersen LPH, Zhou Z, Galano A, et al. Melatonin: an ancient molecule that makes oxygen metabolically tolerable. J Pineal Res. 2015;59:403–19.

CAS  PubMed  Article  Google Scholar 

Suofu Y, Li W, Jean-Alphonse FG, Jia J, Khattar NK, Li J, et al. Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release. Proceedings of the National Academy of Sciences. 2017;114:E7997-E8006.

Zhao D, Yu Y, Shen Y, Liu Q, Zhao Z, Sharma R, et al. Melatonin synthesis and function: evolutionary history in animals and plants. Front Endocrinol. 2019;10:249.

Article  Google Scholar 

Zisapel N. New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. Br J Pharmacol. 2018;175:3190–9.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Skwarlo-Sonta K, Majewski P, Markowska M, Oblap R, Olszanska B. Bidirectional communication between the pineal gland and the immune system. Can J Physiol Pharmacol. 2003;81:342–9.

CAS  PubMed  Article  Google Scholar 

Hardeland R. Aging, melatonin, and the pro-and anti-inflammatory networks. Int J Mol Sci. 2019;20:1223.

CAS  PubMed Central  Article  Google Scholar 

Talib WH, Alsayed AR, Abuawad A, Daoud S, Mahmod AI. Melatonin in cancer treatment: Current knowledge and future opportunities. Molecules. 2021;26:2506.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Mao L, Summers W, Xiang S, Yuan L, Dauchy RT, Reynolds A, et al. Melatonin Represses Metastasis in Her2-Postive Human Breast Cancer Cells by Suppressing RSK2 ExpressionMelatonin Represses Rsk of Breast Cancer Metastasis. Mol Cancer Res. 2016;14:1159–69.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Wang SW, Tai HC, Tang CH, Lin LW, Lin TH, Chang AC, et al. Melatonin impedes prostate cancer metastasis by suppressing MMP-13 expression. J Cell Physiol. 2021;236:3979–90.

CAS  PubMed  Article  Google Scholar 

Dubocovich ML. Melatonin receptors: role on sleep and circadian rhythm regulation. Sleep Med. 2007;8:34–42.

PubMed  Article  Google Scholar 

Becker-André M, Wiesenberg I, Schaeren-Wiemers N, André E, Missbach M, Saurat J-H, et al. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J Biol Chem. 1994;269:28531–4.

PubMed  Article  Google Scholar 

Ma H, Kang J, Fan W, He H, Huang F. ROR: Nuclear receptor for melatonin or not? Molecules. 2021;26:2693.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Boutin JA, Ferry G. Is there sufficient evidence that the melatonin binding site MT3 is quinone reductase 2? J Pharmacol Exp Ther. 2019;368:59–65.

CAS  PubMed  Article  Google Scholar 

Hunt AE, Al-Ghoul WM, Gillette MU, Dubocovich ML. Activation of MT2 melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock. Am J Physiology-Cell Physiol. 2001;280:C110-C8.

Article  Google Scholar 

Jockers R, Maurice P, Boutin J, Delagrange P. Melatonin receptors, heterodimerization, signal transduction and binding sites: what’s new? Br J Pharmacol. 2008;154:1182–95.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Dubocovich ML, Markowska M. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine. 2005;27:101–10.

CAS  PubMed  Article  Google Scholar 

Slominski RM, Reiter RJ, Schlabritz-Loutsevitch N, Ostrom RS, Slominski AT. Melatonin membrane receptors in peripheral tissues: distribution and functions. Mol Cell Endocrinol. 2012;351:152–66.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Capote-Moreno A, Ramos E, Egea J, López-Muñoz F, Gil-Martín E, Romero A. Potential of melatonin as adjuvant therapy of oral cancer in the era of epigenomics. Cancers. 2019;11:1712.

CAS  PubMed Central  Article  Google Scholar 

Cavalli G, Heard E. Advances in epigenetics link genetics to the environment and disease. Nature. 2019;571:489–99.

CAS  PubMed  Article  Google Scholar 

Moosavi A, Ardekani AM. Role of epigenetics in biology and human diseases. Iran Biomed J. 2016;20:246.

PubMed  PubMed Central  Google Scholar 

Bates SE. Epigenetic therapies for cancer. N Engl J Med. 2020;383:650–63.

CAS  PubMed  Article  Google Scholar 

Cheng Y, He C, Wang M, Ma X, Mo F, Yang S, et al. Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials. Signal Transduct Target therapy. 2019;4:1–39.

Article  Google Scholar 

Surace AEA, Hedrich CM. The role of epigenetics in autoimmune/inflammatory disease. Frontiers in immunology. 2019:1525.

Prasher D, Greenway SC, Singh RB. The impact of epigenetics on cardiovascular disease. Biochem Cell Biol. 2020;98:12–22.

CAS  PubMed  Article  Google Scholar 

Ling C, Rönn T. Epigenetics in human obesity and type 2 diabetes. Cell Metabol. 2019;29:1028–44.

CAS  Article  Google Scholar 

Klutstein M, Nejman D, Greenfield R, Cedar H. DNA Methylation in Cancer and Aging. Cancer Res. 2016;76:3446–50.

CAS  PubMed  Article  Google Scholar 

Angeloni A, Bogdanovic O. Sequence determinants, function, and evolution of CpG islands. Biochem Soc Trans. 2021;49:1109–19.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Carlberg C, Molnár F. Human epigenomics. Springer; 2018.

Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16:6–21.

CAS  PubMed  Article  Google Scholar 

Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science. 2001;293:1089–93.

CAS  PubMed  Article  Google Scholar 

Kim M, Costello J. DNA methylation: an epigenetic mark of cellular memory. Exp Mol Med. 2017;49:e322-e. doi:https://doi.org/10.1038/emm.2017.10.

CAS  Article  Google Scholar 

Noroozi R, Ghafouri-Fard S, Pisarek A, Rudnicka J, Spólnicka M, Branicki W, et al. DNA methylation-based age clocks: from age prediction to age reversion. Ageing Res Rev. 2021;68:101314.

CAS  PubMed  Article  Google Scholar 

Skvortsova K, Stirzaker C, Taberlay P. The DNA methylation landscape in cancer. Essays Biochem. 2019;63:797–811.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Wilson AG. Epigenetic regulation of gene expression in the inflammatory response and relevance to common diseases. J Periodontol. 2008;79:1514–9.

CAS  PubMed  Article  Google Scholar 

Magaña-Acosta M, Valadez-Graham V. Chromatin remodelers in the 3D nuclear compartment. Frontiers in Genetics. 2020:1344.

Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet. 2008;9:465–76.

CAS  PubMed  Article  Google Scholar 

Ng H-H, Zhang Y, Hendrich B, Johnson CA, Turner BM, Erdjument-Bromage H, et al. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat Genet. 1999;23:58–